We diagnose chronic illness for the sector as its long-held pricing tooth decays and accountability is forced upon it.
This study discovers and explains why life won’t be same (or as good) again!
Our Lead Analyst on Healthcare & Pharma has published her latest note entitled “Tough times ahead”.
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
|Trading in corporate shares||NO|
|Advising of corporate (strategy, marketing, debt, etc)||NO|
|Research paid for by corporate||NO|
|Provision of corporate access paid for by corporate||NO|
|Link between and a banking entity||NO|
|Brokerage activity at AlphaValue||NO|